Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Oncotargets and Therapy
|
August 18, 2020
MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway
Shengya Cao, Longfei Li, Jia Li, et al.
Molecular Biology of the Cell
|
January 19, 2018
Constitutive centromere-associated network contacts confer differential stability on CENP-A nucleosomes in vitro and in the cell
Shengya Cao, Keda Zhou, Zhening Zhang, et al.
Cell Biology and Toxicology
|
June 8, 2022
Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091
Qiang Wang, Chunmei Zhang, Shengya Cao, et al.
Oncotargets and Therapy
|
October 16, 2020
Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization
Shengya Cao, Shuo Zhu, Wei Yin, et al.
Communications Biology
|
August 5, 2022
Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike
Bushra Husain, Kobe Yuen, Dawei Sun, et al.
Cancer Management and Research
|
July 26, 2021
The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
Shuo Zhu, Shengya Cao, Weibin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 2021
A membrane protein display platform for receptor interactome discovery
Shengya Cao, Sean M Peterson, Sören Müller, et al.
Oncotargets and Therapy
|
March 19, 2020
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
Rong Ma, Qing Yang, Shengya Cao, et al.
Current Protocols
|
July 13, 2022
Receptor Interactome Discovery with RDIMIS, a Membrane Protein Interaction Screen Using Recombinant Extracellular Vesicles
Ariana D Sanchez, Sean M Peterson, Mike Reichelt, et al.
Oncology Research
|
June 26, 2026
Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer
Jinhui Che, Zhiyuan Chen, Feng Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Oncotargets and Therapy
|
August 18, 2020
MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway
Shengya Cao, Longfei Li, Jia Li, et al.
Molecular Biology of the Cell
|
January 19, 2018
Constitutive centromere-associated network contacts confer differential stability on CENP-A nucleosomes in vitro and in the cell
Shengya Cao, Keda Zhou, Zhening Zhang, et al.
Cell Biology and Toxicology
|
June 8, 2022
Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091
Qiang Wang, Chunmei Zhang, Shengya Cao, et al.
Oncotargets and Therapy
|
October 16, 2020
Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization
Shengya Cao, Shuo Zhu, Wei Yin, et al.
Communications Biology
|
August 5, 2022
Cell-based receptor discovery identifies host factors specifically targeted by the SARS CoV-2 spike
Bushra Husain, Kobe Yuen, Dawei Sun, et al.
Cancer Management and Research
|
July 26, 2021
The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
Shuo Zhu, Shengya Cao, Weibin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 17, 2021
A membrane protein display platform for receptor interactome discovery
Shengya Cao, Sean M Peterson, Sören Müller, et al.
Oncotargets and Therapy
|
March 19, 2020
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
Rong Ma, Qing Yang, Shengya Cao, et al.
Current Protocols
|
July 13, 2022
Receptor Interactome Discovery with RDIMIS, a Membrane Protein Interaction Screen Using Recombinant Extracellular Vesicles
Ariana D Sanchez, Sean M Peterson, Mike Reichelt, et al.
Oncology Research
|
June 26, 2026
Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer
Jinhui Che, Zhiyuan Chen, Feng Zhang, et al.
Page
of 2